A Phase I Evaluating Integration of HypofractionatedStudy Renal Ablative Radiotherapy
NCT02264548
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Renal Cell Carcinoma
Interventions
RADIATION:
Radio-Ablation
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's